The Renin-Angiotensin-Aldosterone System and Heart Failure
- 1 February 2014
- journal article
- review article
- Published by Elsevier BV in Cardiology Clinics
- Vol. 32 (1), 21-32
- https://doi.org/10.1016/j.ccl.2013.09.002
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Eplerenone in Patients with Systolic Heart Failure and Mild SymptomsThe New England Journal of Medicine, 2011
- HFSA 2010 Comprehensive Heart Failure Practice GuidelineJournal of Cardiac Failure, 2010
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseThe New England Journal of Medicine, 2004
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureThe New England Journal of Medicine, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureThe New England Journal of Medicine, 1999
- Modulation of hemodynamic effects with a converting enzyme inhibitor: Acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesAmerican Heart Journal, 1988
- Enalapril for Congestive Heart FailureThe New England Journal of Medicine, 1987
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.Circulation, 1984